Cardinal Health Inc (CAH) Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
Cardinal Health Inc (NYSE: CAH) FY 2026 Other Release
34 articles, transcripts, and reports
Cardinal Health Inc (NYSE: CAH) FY 2026 Other Release
Cardinal Health Inc (NYSE: CAH) Q3 2026 Earnings Conference
Cardinal Health Inc (NYSE: CAH) Sec Form 8K
Cardinal Health Inc (NYSE: CAH) FY 2026 Management Update
Cardinal Health Inc (NYSE: CAH) Sec Form 8K
Cardinal Health Inc (NYSE: CAH) FY 2026 Other Release
Cardinal Health Inc (NYSE: CAH) Q1 2026 Dividend Update
Cardinal Health Inc (NYSE: CAH) Sec Form 10Q
Cardinal Health Inc (NYSE: CAH) Sec Form 8K
Cardinal Health Inc (NYSE: CAH) Q1 2022 Earnings Call dated Nov. 09, 2021 Corporate Participants: Kevin Moran — Vice President of Investor Relations Michael Kaufmann…